Independent Director · Sage Therapeutics, Inc. (SAGE)

Geno Germano — Sage Therapeutics Director Compensation (2024)

Fiscal year 2024 director compensation for Geno Germano at Sage Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2025 (DEF 14A). Open the filing on EDGAR.

What they were paid

Sage Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Sage Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$98,682—$91,810—$190,492

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sage Therapeutics, Inc. DEF 14A filed April 24, 2025, accession 0000950170-25-058060, and prior-year filings. Open the filing on EDGAR.

The rest of the Sage Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Elizabeth BarrettIndependent Director$159,310
George GolumbeskiIndependent Director$146,810
James M. FratesIndependent Director$169,310
Jeffrey M. JonasIndependent Director$191,453
Jessica FedererIndependent Director$151,673
Kevin P. StarrIndependent Director$1,161
Michael F. ColaIndependent Director$167,220
Steven PaulIndependent Director$27,835

The full Sage Therapeutics compensation record

free company brief

This page is one director within Sage Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy